ファイザーのRWD事例 CDK4/6阻害剤+レトロゾール vs レトロゾールのPFSとOSを RWEで大規模有効性比較解析 https://t.co/FU0jLMaR3z 元論文/Breast Cancer Research https://t.co/HO4JvKO6wa
"In this “real-world” population of patients with HR+/HER2− MBC, #palbociclib in combination with endocrine therapy was associated with improved survival outcomes compared with patients treated with #letrozole alone in the first-line setting." https://t.
#BestStudyoftheDay: Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer https://t.co/guEOC8RVjP - Breast Cancer Res - #senology #breast #cancer #oncology
Read 'Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice' from #BreastCancerResearch for free: https://t.co/EUIkwwfSjC #Palbociclib #Letrozole